Literature DB >> 24402709

Immunopathology of lupus nephritis.

Hans-Joachim Anders1, Agnes B Fogo.   

Abstract

When patients with systemic lupus erythematosus (SLE) present with urinary abnormalities, a renal biopsy is usually needed to rule out or confirm lupus nephritis. Renal biopsy is also needed to define the type of renal manifestation as different entities are associated with different outcomes; hence, renal biopsy results shape lupus management. But why does lupus nephritis come in different shapes? Why do patients with SLE often show change over time in class of lupus nephritis or have mixed forms? How does autoimmunity in SLE evolve? Why does loss of tolerance against nuclear antigens preferentially affect the kidney? Why are immune complex deposits in different glomerular compartments associated with different outcomes? What determines crescent formation in lupus? In this review, we discuss these questions by linking the latest information on lupus pathogenesis into the context of the different classes of lupus nephritis. This should help the basic scientist, the pathologist, and the clinician to gain a more conceptual view on the immunopathology of lupus nephritis.

Entities:  

Mesh:

Year:  2014        PMID: 24402709     DOI: 10.1007/s00281-013-0413-5

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  122 in total

1.  Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.

Authors:  Kai W Bekar; Teresa Owen; Robert Dunn; Travis Ichikawa; Wensheng Wang; Roger Wang; Jennifer Barnard; Sean Brady; Sarah Nevarez; Bruce I Goldman; Marilyn Kehry; Jennifer H Anolik
Journal:  Arthritis Rheum       Date:  2010-08

2.  Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.

Authors:  Eneida Villanueva; Srilakshmi Yalavarthi; Celine C Berthier; Jeffrey B Hodgin; Ritika Khandpur; Andrew M Lin; Cory J Rubin; Wenpu Zhao; Stephen H Olsen; Matthew Klinker; David Shealy; Michael F Denny; Joel Plumas; Laurence Chaperot; Matthias Kretzler; Allen T Bruce; Mariana J Kaplan
Journal:  J Immunol       Date:  2011-05-25       Impact factor: 5.422

3.  Factors associated with poor outcomes in patients with lupus nephritis.

Authors:  G Contreras; V Pardo; C Cely; E Borja; A Hurtado; C De La Cuesta; K Iqbal; O Lenz; A Asif; N Nahar; B Leclerq; C Leon; I Schulman; F Ramirez-Seijas; A Paredes; A Cepero; T Khan; F Pachon; E Tozman; G Barreto; D Hoffman; M Almeida Suarez; J C Busse; M Esquenazi; A Esquenazi; L Garcia Mayol; H Garcia Estrada
Journal:  Lupus       Date:  2005       Impact factor: 2.911

4.  Complement factor H deficiency accelerates development of lupus nephritis.

Authors:  Lihua Bao; Mark Haas; Richard J Quigg
Journal:  J Am Soc Nephrol       Date:  2010-12-09       Impact factor: 10.121

Review 5.  IL-17-producing T cells in lupus nephritis.

Authors:  S A Apostolidis; J C Crispín; G C Tsokos
Journal:  Lupus       Date:  2011-02       Impact factor: 2.911

6.  Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.

Authors:  Ramanjaneyulu Allam; Christina Rebecca Scherbaum; Murthy Narayana Darisipudi; Shrikant R Mulay; Holger Hägele; Julia Lichtnekert; Jan Henrik Hagemann; Khader Valli Rupanagudi; Mi Ryu; Claudia Schwarzenberger; Bernd Hohenstein; Christian Hugo; Bernd Uhl; Christoph A Reichel; Fritz Krombach; Marc Monestier; Helen Liapis; Kristin Moreth; Liliana Schaefer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2012-06-07       Impact factor: 10.121

7.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

Review 8.  TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization.

Authors:  Cecilia Garlanda; Hans-Joachim Anders; Alberto Mantovani
Journal:  Trends Immunol       Date:  2009-08-21       Impact factor: 16.687

9.  Viral RNA and DNA trigger common antiviral responses in mesangial cells.

Authors:  Ramanjaneyulu Allam; Julia Lichtnekert; Anton G Moll; Anela Taubitz; Volker Vielhauer; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

10.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.

Authors:  E Cornacchia; J Golbus; J Maybaum; J Strahler; S Hanash; B Richardson
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

View more
  14 in total

Review 1.  Redefining lupus nephritis: clinical implications of pathophysiologic subtypes.

Authors:  Feng Yu; Mark Haas; Richard Glassock; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

2.  Glomerular disease: Personalized immunomonitoring in lupus and lupus nephritis.

Authors:  Hans-Joachim Anders; Matthias Kretzler
Journal:  Nat Rev Nephrol       Date:  2016-05-09       Impact factor: 28.314

3.  The expression of EBV-encoded LMP1 in young patients with lupus nephritis.

Authors:  Yan Ding; Xiaojie He; Wang Liao; Zhuwen Yi; Huilan Yang; Wei Xiang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity.

Authors:  Jiabin Wu; Lixin Wei; Weiming Wang; Xianghui Zhang; Li Chen; Changda Lin
Journal:  Rheumatol Int       Date:  2016-03-11       Impact factor: 2.631

5.  Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.

Authors:  Ling Sun; Lu-Xi Zou; Yu-Chen Han; Dong-Dong Zhu; Ting Chen; Jie Wang
Journal:  Clin Exp Nephrol       Date:  2019-12-07       Impact factor: 2.801

6.  Class II lupus nephritis with podocyte injury in imiquimod-induced lupus-prone mice.

Authors:  Atsuko Murai; Masaki Yamazaki; Kaori Nishihara; Aki Kito; Sohei Oyama; Naoshi Horiba; Atsuhiko Kato
Journal:  Histol Histopathol       Date:  2022-03-17       Impact factor: 2.130

Review 7.  Herpesviruses dUTPases: A New Family of Pathogen-Associated Molecular Pattern (PAMP) Proteins with Implications for Human Disease.

Authors:  Marshall V Williams; Brandon Cox; Maria Eugenia Ariza
Journal:  Pathogens       Date:  2016-12-28

Review 8.  Pediatric lupus nephritis.

Authors:  Sergio Veloso Brant Pinheiro; Raphael Figuiredo Dias; Rafaela Cabral Gonçalves Fabiano; Stanley de Almeida Araujo; Ana Cristina Simões E Silva
Journal:  J Bras Nefrol       Date:  2018-11-14

9.  CXCL13 Promotes Proliferation of Mesangial Cells by Combination with CXCR5 in SLE.

Authors:  Zhanyun Da; Liuxia Li; Jin Zhu; Zhifeng Gu; Bo You; Ying Shan; Si Shi
Journal:  J Immunol Res       Date:  2016-09-08       Impact factor: 4.818

10.  Interferon (IFN)-λ is a potential mediator in lupus nephritis.

Authors:  Agneta Zickert; Vilija Oke; Ioannis Parodis; Elisabet Svenungsson; Yvonne Sundström; Iva Gunnarsson
Journal:  Lupus Sci Med       Date:  2016-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.